A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells - PubMed (original) (raw)
. 1996 Sep 27;271(39):24063-8.
doi: 10.1074/jbc.271.39.24063.
Affiliations
- PMID: 8798643
- DOI: 10.1074/jbc.271.39.24063
Free article
A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells
M L Lupher Jr et al. J Biol Chem. 1996.
Free article
Abstract
The protooncogene product Cbl has emerged as a novel signal transduction protein downstream of a number of cell surface receptors coupled to tyrosine kinases. Recently, we and others have reported the activation-dependent association of Cbl with the Syk and ZAP-70 tyrosine kinases through presently undefined mechanisms. Potential Src homology 2 and 3 domain binding sites within the C-terminal half of Cbl mediate in vivo interactions with several signaling proteins; however, the N-terminal transforming region (Cbl-N) lacks recognizable catalytic or protein interaction motifs. Here, we show that in vitro Cbl-N (amino acids 1-357) but not Cbl-C (amino acids 358-906) binds to ZAP-70 in a T cell-activation-dependent manner. A point mutation in Cbl-N, G306E, corresponding to a loss-of-function mutation in the Caenorhabditis elegans Cbl homologue, SLI-1, severely compromised Cbl-N/ZAP-70 binding. Cbl-N/ZAP-70 binding was direct and phosphotyrosine-dependent, thus identifying a phosphotyrosine-binding domain within the transforming region of Cbl. In vivo, Cbl-N expressed in T cells selectively associated with the ZAP-70/zeta complex. These results identify a novel mechanism for the direct participation of the N-terminal region of Cbl in ZAP-70 signal transduction, and suggest a biochemical mechanism for the leukemogenicity of the oncogene v-cbl through potential interaction with proliferation-related phosphotyrosyl proteins.
Similar articles
- The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells.
van Leeuwen JE, Paik PK, Samelson LE. van Leeuwen JE, et al. Mol Cell Biol. 1999 Oct;19(10):6652-64. doi: 10.1128/MCB.19.10.6652. Mol Cell Biol. 1999. PMID: 10490604 Free PMC article. - Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.
Lupher ML Jr, Rao N, Lill NL, Andoniou CE, Miyake S, Clark EA, Druker B, Band H. Lupher ML Jr, et al. J Biol Chem. 1998 Dec 25;273(52):35273-81. doi: 10.1074/jbc.273.52.35273. J Biol Chem. 1998. PMID: 9857068 - The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.
Miyake S, Lupher ML Jr, Andoniou CE, Lill NL, Ota S, Douillard P, Rao N, Band H. Miyake S, et al. Crit Rev Oncog. 1997;8(2-3):189-218. doi: 10.1615/critrevoncog.v8.i2-3.30. Crit Rev Oncog. 1997. PMID: 9570294 Review. - The Cbl family of signal transduction molecules.
Smit L, Borst J. Smit L, et al. Crit Rev Oncog. 1997;8(4):359-79. doi: 10.1615/critrevoncog.v8.i4.50. Crit Rev Oncog. 1997. PMID: 9622055 Review.
Cited by
- T cell receptor (TCR) signaling in health and disease.
Shah K, Al-Haidari A, Sun J, Kazi JU. Shah K, et al. Signal Transduct Target Ther. 2021 Dec 13;6(1):412. doi: 10.1038/s41392-021-00823-w. Signal Transduct Target Ther. 2021. PMID: 34897277 Free PMC article. Review. - All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal.
Margiotta A. Margiotta A. Int J Mol Sci. 2021 Jun 14;22(12):6342. doi: 10.3390/ijms22126342. Int J Mol Sci. 2021. PMID: 34198477 Free PMC article. Review. - Cbl-b deficiency prevents functional but not phenotypic T cell anergy.
Nguyen TTT, Wang ZE, Shen L, Schroeder A, Eckalbar W, Weiss A. Nguyen TTT, et al. J Exp Med. 2021 Jul 5;218(7):e20202477. doi: 10.1084/jem.20202477. Epub 2021 May 11. J Exp Med. 2021. PMID: 33974042 Free PMC article. - UBASH3A Regulates the Synthesis and Dynamics of TCR-CD3 Complexes.
Ge Y, Paisie TK, Chen S, Concannon P. Ge Y, et al. J Immunol. 2019 Dec 1;203(11):2827-2836. doi: 10.4049/jimmunol.1801338. Epub 2019 Oct 28. J Immunol. 2019. PMID: 31659016 Free PMC article. - Strategies to enhance NK cell function for the treatment of tumors and infections.
Freund-Brown J, Chirino L, Kambayashi T. Freund-Brown J, et al. Crit Rev Immunol. 2018;38(2):105-130. doi: 10.1615/CritRevImmunol.2018025248. Crit Rev Immunol. 2018. PMID: 29953390 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous